The largest database of trusted experimental protocols

A549 cis cells

Sourced in United States

A549/CIS cells are a subline of the A549 human lung carcinoma cell line. They are derived from the parental A549 cells through continuous exposure to cisplatin, a chemotherapeutic agent. The A549/CIS cells exhibit increased resistance to cisplatin compared to the original A549 cell line.

Automatically generated - may contain errors

2 protocols using a549 cis cells

1

Culturing CIS-resistant NSCLC and Normal Lung Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CIS-resistant NSCLC cells (A549/CIS cells) and Human normal lung epithelial cells (BEAS-2B cells) were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured (37°C, 5% CO2) in DMEM medium (10% FBS, 100 U/mL penicillin, 0.1 mg/mL streptomycin).
+ Open protocol
+ Expand
2

PEGylated Transferrin-Targeted Nanocarriers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soya lecithin (SL, injectable) was provided by Lipoid GmbH (Ludwigshafen, Germany). Compritol® 888 ATO (ATO) was a gift from Gattefossé (Saint-Priest, Lyon, France). DSPE-PEG2000-COOH was produced by Seebio Biotech (Shanghai) Co., Ltd. (Shanghai, China). Transferrin, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), N-Hydroxysuccinimide (NHS), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) were bought from Sigma Aldrich (St. Louis, MO). The CIS resistant NSCLC cell line (A549/CIS cells), another NSCLC cell line (H1975 cells), and human normal lung epithelial cells (BEAS-2B cells) were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in RPMI Medium 1640 supplemented with 10% (v/v) FBS and 1% (v/v) penicillin–streptomycin at 37°C in an atmosphere of 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!